In the Netherlands, IFF announced the launch of its new Designed Enzymatic Biomaterials (DEB) technology for the development of biobased materials at scale.
IFF noted that its new DEB technology helps to address growing preferences for environmentally-friendly, high-performance biopolymers.
The technology platform offers manufacturers the opportunity to meet regulatory changes and mounting consumer demands to replace traditional fossil-based synthetic polymers, IFF added.
“With the DEB technology platform, scientists can now build the functions of petroleum-based polymers into biopolymer materials directly – customizing and fine-tuning polysaccharides to enable sustainable performance enhancements within the chosen application,” said Wayne Ashton, VP of Home and Personal Care at IFF.
More on the story.
